Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

por Glaysher, Sharon, Bolton, Louise M, Johnson, Penny, Torrance, Christopher, Cree, Ian A
Publicado 2014

The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours

por Knight, Louise A, Di Nicolantonio, Federica, Whitehouse, Pauline, Mercer, Stuart, Sharma, Sanjay, Glaysher, Sharon, Johnson, Penny, Cree, Ian A
Publicado 2004

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

por Bhandari, Pradeep, Bateman, Adrian C, Mehta, Raj L, Stacey, Bernard SF, Johnson, Penny, Cree, Ian A, Di Nicolantonio, Federica, Patel, Praful
Publicado 2006

Cancer cell adaptation to chemotherapy

por Di Nicolantonio, Federica, Mercer, Stuart J, Knight, Louise A, Gabriel, Francis G, Whitehouse, Pauline A, Sharma, Sanjay, Fernando, Augusta, Glaysher, Sharon, Di Palma, Silvana, Johnson, Penny, Somers, Shaw S, Toh, Simon, Higgins, Bernie, Lamont, Alan, Gulliford, Tim, Hurren, Jeremy, Yiangou, Constantinos, Cree, Ian A
Publicado 2005

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)

por Glaysher, Sharon, Yiannakis, Dennis, Gabriel, Francis G, Johnson, Penny, Polak, Marta E, Knight, Louise A, Goldthorpe, Zoe, Peregrin, Katharine, Gyi, Mya, Modi, Paul, Rahamim, Joe, Smith, Mark E, Amer, Khalid, Addis, Bruce, Poole, Matthew, Narayanan, Ajit, Gulliford, Tim J, Andreotti, Peter E, Cree, Ian A
Publicado 2009